tiprankstipranks
Viva Biotech Holdings (HK:1873)
:1873
Hong Kong Market
1873
Viva Biotech Holdings
RESEARCH TOOLSreports
Want to see HK:1873 full AI Analyst Report?

Viva Biotech Holdings (1873) Income Statement

4 Followers

Viva Biotech Holdings Income Statement

Last quarter (Q4 2025), Viva Biotech Holdings's total revenue was ¥897.57M, a decrease of -11.43% from the same quarter last year. In Q4, Viva Biotech Holdings's net income was ¥97.96M. See Viva Biotech Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 1.73B¥ 1.99B¥ 2.16B¥ 2.38B¥ 2.10B
Gross Profit
¥ 655.56M¥ 687.40M¥ 738.43M¥ 815.68M¥ 650.98M
Operating Expenses
¥ 462.31M¥ 457.73M¥ 545.75M¥ 546.33M¥ 414.08M
Depreciation and Amortization
¥ 192.13M¥ 198.33M¥ 198.33M¥ 170.37M¥ 133.04M
EBITDA
¥ 385.38M¥ 428.00M¥ 391.01M¥ 436.35M¥ 369.94M
Operating Income
¥ 193.25M¥ 229.67M¥ 192.68M¥ 269.35M¥ 236.90M
Other Income/Expenses
¥ 124.75M¥ 66.04M¥ -248.64M¥ -728.51M¥ 110.80M
Pretax Income
¥ 318.00M¥ 295.70M¥ -55.95M¥ -459.17M¥ 347.70M
Net Income
¥ 219.76M¥ 167.29M¥ -116.11M¥ -528.48M¥ 287.55M
Per Share Metrics
Basic EPS
¥ 0.10¥ 0.08¥ -0.06¥ -0.28¥ 0.15
Diluted EPS
¥ 0.09¥ 0.06¥ -0.06¥ -0.28¥ 0.15
Weighted Average Shares Outstanding
 2.44B 2.14B 1.94B 1.89B 1.91B
Weighted Average Shares Outstanding (Diluted)
 2.34B 2.87B 2.03B 1.92B 1.97B
Currency in CNY

Viva Biotech Holdings Earnings and Revenue History